Source: MicroConstants Blog

MicroConstants Blog Neoantigens Revive Vaccine Opportunities in Immuno-Oncology

Neoantigens are novel proteins that form on cancer cells following the development of mutations in the tumor-cell DNA. These proteins are new to the immune system and are not part of the collection of self-proteins to which immune cells are tolerant or non-responsive. Therefore, neoantigens have the ability to trigger an impressive and very specific [...]Share ThisThe post Neoantigens Revive Vaccine Opportunities in Immuno-Oncology appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Gilbert Lam's photo - President of MicroConstants

President

Gilbert Lam

CEO Approval Rating

90/100

Read more